PhRMA Statement on Childhood Vaccine Schedule Executive Order

WASHINGTON, D.C. (AUGUST 10, 2026) - Pharmaceutical Research and Manufacturers of America (PhRMA) Chief Medical Officer Dr. Michael Ybarra issued the following statement in response to today's Executive Order on childhood vaccine recommendations and immunization policy:

"America's childhood immunization schedule is built on decades of rigorous scientific research and public health expertise designed for the U.S. population. Any changes to the childhood vaccine schedule, vaccine formulations and ingredients should be driven by the same high standard of evidence and focused on protecting children from serious and potentially life-threatening diseases. Simply imposing a narrower schedule by importing recommendations from foreign countries wouldn't reflect gold standard science - it would mean accepting a lower bar of protection against diseases that remain serious and, in some cases, life-threatening for children in the United States.

Dive deeper from PhRMA:

Changes to America's childhood vaccine schedule fail to protect our nation's kids

Vaccines and autism: Decades of scientific evidence find no link

Explore more at PhRMA.org/Vaccines

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading innovative biopharmaceutical research companies, which are focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. PhRMA member companies have invested more than $850 billion in the search for new treatments and cures over the last decade, supporting nearly five million jobs in the United States.

Connect with PhRMA

For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.Innovation.org
www.VotersforCures.org
www.AmericasMedicines.com
www.LinkedIn.com/Company/PhRMA
www.X.com/PhRMA